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Objective. To report on the incidence and factors associated with the development of perioperative neurological complications
following CEA in patients affected by carotid stenosis with contralateral occlusion (CO) and to compare results between those
patients and thewhole group of patients submitted toCEA at our vascular division from 1997 to 2012.Methods. Our nonrandomized
prospective experience including 1639 patients consecutively submitted toCEAwas retrospectively reviewed. 136 patients presented
a CO contralateral to the treated carotid stenosis. Outcomes considered for analysis were perioperative neurological death rates,
major andminor stroke rates, and a combined endpoint of all neurological complications.Results. COpatientsmore frequently were
male, smokers, younger, and symptomatic (P < 0.001), presented with a preoperative brain infarct and associated peripheral arterial
disease (P < 0.0001), and presented with higher perioperative major stroke rate than patients without CO (4.4% versus 1.2%, resp.,
P = 0.009). Factors associated with the highest neurological risk in CO patients were age >74 years and preoperative brain infarct
(P = 0.03). The combination of the abovementioned factors significantly increased complication rates in CO patients submitted to
CEA. Conclusions. In our experience CO patients were at high risk for postoperative neurological complications particularly when
presenting association of advanced age and preoperative brain infarction.
1. Introduction
Patients presenting a carotid stenosis and contralateral occlu-
sion (CO) have been historically considered at high risk
for carotid endarterectomy (CEA), since results from ran-
domized controlled trials (RCTs) on carotid surgery have
reported morbidity and mortality rates significantly higher
than in the general population affected by carotid stenosis [1–
5]. Hence, that group of patients has been frequently excluded
from surgical treatment in someprospectiveRCTs comparing
results in CEA and carotid artery stenting (CAS) in the
following years, as in the SAPPHIRE trial. On the other hand,
some single-center reports have highlighted a nondissimilar
rate of complications in patients presenting with a carotid
stenosis with or without contralateral occlusion [6–10]. In
those studies perioperative complications are reported in
0.7 to 6.9% of patients presenting with carotid stenosis and
contralateral occlusion, thus reaching percentages consistent
with international recommendations for CEA postoperative
complications in symptomatic patients, but surely exceeding
those requested for CEA in asymptomatic ones [11, 12].
However, within the population of patients affected by carotid
stenosis and contralateral occlusion, different risk categories
could be identified with respect to general medical con-
ditions and involvement of other vascular districts in the
atherosclerotic process, as well as with respect to presence
of previous brain infarct on neuroimaging. It has to be
noted that frequently patients affected by CO have been
included in the “high-surgical risk” category mixed with
patients presenting generalmedical conditions at high risk for
surgery, thus generating confusionwith regard to the real risk
addressed by those patients [5, 7, 8, 10].
We retrospectively reviewed our database on carotid
endarterectomy to analyse the incidence of postoperative
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neurological complications in patients affected by carotid
stenosis and chronic contralateral occlusion, to analyse fac-
tors associated with the development of complications in this
group of patients, and to compare their results with those
obtained in the group of patients without CO submitted to
CEA at our vascular surgery division.
2. Methods
From January 1997 to December 2012, 1639 patients under-
went primary CEA at our vascular surgery division. Data
on demographics, risk factors, preoperative neurological
evaluation and imaging, intervention, and 30-day outcomes
were prospectively collected in our institutional database.
From the database 136 out of 1639 (8.3%) patients presenting a
stenosis of internal carotid artery with a contralateral internal
carotid occlusion (CO) submitted to carotid endarterectomy
in the stenotic side were identified. A carotid stenosis ≥70%
in asymptomatic patients or ≥50% (NASCET [1] stenosis
evaluation criteria) in symptomatic patients was consid-
ered indication for intervention. Patients were considered
symptomatic if they presented carotid-related neurological
symptoms in the previous six months before operation.
Patients submitted to carotid endarterectomy in urgency
(within 2 weeks from last neurological symptom ipsilateral
to the carotid stenosis or occlusion) were not considered for
analysis in the present series because they represent a subset
of patients at higher surgical risk.
All patients preoperatively underwent a complete med-
ical examination, assessment of preoperative neurological
examination by the neurologist by use of National Institute
of Health Stroke Scale (NIHSS) or Rankin Scale evaluation,
blood test, electrocardiogram, and carotid duplex ultrasound
imaging to assess the degree of stenosis. Brain computed
tomography (CT) or magnetic resonance imaging (MRI)
was performed in all CO patients and in all control sample
patients with symptomatic or ulcerated/irregular carotid
plaque detected at duplex ultrasound examination. Before
admission, all patients classified as having a carotid occlusion
had been previously submitted to at least two different
imaging modalities to confirm the obstruction (duplex US,
contrast-enhanced supra-aortic vessels CT scans and MRI).
Patients were operated on on cervical block anaesthesia
or, alternatively, general anaesthesia whenever a local anaes-
thesia was not feasible for patient-related causes.
Patients under local cervical anaesthesia were assessed for
neurological deficit and pain throughout the entire procedure
by hand-grip test.
During operations under general anaesthesia neuro-
logical monitoring was performed by transcranial doppler
(TCD) whenever possible and adjunctive quantitative elec-
troencephalogram (QEEG). Cerebral protection by Sundt
shunting was selectively used when mean velocity in the
middle cerebral artery at TCD monitoring decreased to
≤15 cm/sec or a significant alteration in QEEG recording was
detected. Patients were maintained under their scheduled
ASA (100mg) or ticlopidine (250mg) medication and were
postoperatively reevaluated by a neurologist. Postoperative
neuroimaging was performed only in those patients pre-
senting a postoperative neurological deficit. Follow-up was
conducted at our vascular ultrasound laboratory by carotid
DUS and clinical examination at 1, 6, and 12 months and then
annually. When a postoperative complication had occurred
a neurological assessment was scheduled together with addi-
tional 3- and 9-month follow-up visits.
2.1. Definitions and Statistical Analysis. Outcome mea-
sures for analysis were perioperative (30-day) major stroke
(assessed as a neurological deficit lasting more than 24 hours
and scored as NIHSS ≥ 4) [13], minor stroke (assessed as a
neurological deficit lasting more than 24 hours and scored
as NIHSS ≤ 3) [13], and stroke-related or neurological death.
Water-shed infarction (cerebral border-zone infarctions) and
hyperperfusion syndrome (defined as occurrence of severe
unilateral headache, acute changes inmental status, vomiting,
seizures, focal neurologic deficits, and, ultimately, intracra-
nial hemorrhage) occurrence were also recorded. Neurolog-
ical morbidity (major + minor stroke) and mortality were
analyzed according to clinical preoperative demographics
and presentation and intraoperative details and compared
between patients with or without carotid occlusion contralat-
eral to the treated carotid stenosis. We initially performed
univariate comparisons between outcome measures and pre-
operative and intraoperative patients variables. Univariate
predictors that were significant at 𝑃 < 0.05were then entered
into a multivariate model using logistic regression which
was used to generate odds ratios (ORs) and 95% confidence
intervals (CIs) for 30-day neurological outcomes, in order
to identify a subset of patients at high risk for neurological
complications. Statistical significance was set at 𝑃 ≤ 0.05.
3. Results
3.1. BetweenGroups Preoperative Factors Analysis. Thedemo-
graphic characteristics of the two groups (CO and control
patients) are shown in Table 1. Between groups analysis
disclosed that patients with carotid stenosis and contralateral
occlusion (CO group) were significantly younger (67.02± 7.9
versus 69.72 ± 8.13; 𝑃 < 0.0001), were more frequently
males (114 versus 1054; 83.8% versus 68.3%; 𝑃 = 0.001) and
more frequently smokers (103 versus 828; 75.7% versus 53.7%;
𝑃 < 0.0001), and presented a significantly higher incidence of
peripheral arterial disease (45 versus 248; 33.1% versus 16.1%;
𝑃 < 0.0001) than patients without contralateral occlusion
(control group). CO patients referred previous neurological
symptoms ipsilateral to the stenosis in 18 cases out of 86,
and contralateral, or ipsilateral to the carotid occlusion, in 68
cases.
Analysis of neurological presentation before operation
disclosed that CO patients were more frequently symp-
tomatic (86COpatients presenting preoperative neurological
symptoms versus 665 control patients; 63.2% versus 46.4%;
𝑃 < 0.0001) and presented more frequently cerebral infarcts
on preoperative brain imaging (65 CO patients versus 379
control patients; 47.8% versus 25.2%; 𝑃 < 0.0001). One
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Table 1: Analysis of demographic factors in 1639 primary carotid revascularizations.
CO
136 cases
Control group
1503 cases 𝑃
Age (years) 67.02 ± 7.9 69.72 ± 8.13 <0.0001(95% CI: 4.12 ± 1.27)
Sex: males 114 83.8% 1054 68.3% 0.001
Risk factors
Smoke 103 75.7% 828 53.7% <0.0001
Hypertension 104 76.5% 1238 80.2% 0.111
Diabetes 42 30.9% 422 27.3% 0.551
Hyperlipidemia 60 44.1% 637 41.3% 0.763
Ischemic heart disease 41 30.1% 518 33.6% 0.356
Peripheral arterial disease 45 33.1% 248 16.1% <0.0001
Abdominal aortic aneurysm 3 2.2% 72 4.7% 0.243
Neurological presentation
Asymptomatic 50 36.8% 838 55.8%
<0.0001
Symptomatic 86 63.2% 665 46.4%
TIA 60 44.1% 491 32.7%
STROKE 26 19.1% 174 11.6%
Shunt implantation 40 29.4% 121 8% <0.0001
Infarct on neuroimaging∗
<0.0001
Yes 65 47.8% 379 25.2%
Ipsilateral to CEA 12 8.8% 213 14.2%
Contralateral to CEA 41 30.2% 64 4.2%
Bilateral 12 8.8% 102 6.8%
No/NK 71 52.2% 1124 74.8%
CO: contralateral carotid occlusion; NK: not known; ∗detected by either brain CT or MRI.
vertebral artery was occluded in 9 patients in the CO group
and in 25 patients in the control group.
3.2. Between Groups Intraoperative Factors Analysis. CO
patients were more frequently submitted to CEA under local
anaesthesia (93 versus 873; 68.4% versus 58.1%; 𝑃 = 0.02)
and hadmore frequently a shunt implantation after clamping
test (40 versus 121; 29.4% versus 8.1%; 𝑃 < 0.0001). Shunt
use rate was not statistically different in patients submitted to
CEA under local or general anaesthesia in both groups.Mean
clamping time was 23.3 ± 13.5 versus 22.9 ± 12.5 minutes in
CO versus control group (𝑃 = 0.28).
3.3. Between Groups Neurological Outcome Analysis. Periop-
erative (30-day) complications analysis disclosed no signif-
icant difference in neurological mortality rates between the
two groups (𝑃 = 0.28). Incidence of postoperative minor
stroke was not significantly different in the two groups (0.7%
in CO group and 0.5% in control group, resp.), while major
stroke incidence analysis disclosed a statistically significant
difference (4.4% in CO and 1.2% in control group, 𝑃 =
0.009), accounting for higher overall neurological morbidity
and overall neurological complication rates in CO groupwith
respect to control group (5.1% versus 1.7%, 𝑃 = 0.01, and
6.6% versus 2.1%, 𝑃 = 0.003, resp.). In CO patients 5 out
of 9 perioperative neurological complications were related
to technical defects (carotid early thrombosis, 55.5%) while
in control cases carotid early thrombosis was responsible
for neurological events in 24 out of 26 cases (92.3%). In 4
cases in CO group and 2 cases in control group neurological
complications were related to hypoperfusion or reperfusion
injuries (44.5% versus 7.7%). No complication occurred in
CO patients presenting one vertebral artery occluded and 1
major stroke (carotid thrombosis in the first hours following
intervention) occurred in one patient with an occluded
vertebral artery in the control group. Results are summarized
in Table 2.
3.4. Within Group Analysis of Risk Factors for Postoper-
ative Neurological Complications in CO Patients. Analysis
of preoperative clinical factors and neurological outcome
in CO patients disclosed that neurological complications
occurred more frequently in elderly patients (patients with
complications versus patients without complications mean
age 73.55 ± 4.24 versus 66.55 ± 7.9; 95% CI: 1.76–12.27;
𝑃 < 0.01; patients with complications versus patients without
complications and age >74 years 𝑃 = 0.008) and in patients
with cerebral infarct on preoperative neuroimaging (𝑃 =
0.036). Use of shunt did not show to be related to an
increased risk of neurological complications (4 patients in the
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Table 2: Perioperative (30-day) neurological outcomes in 1639 primary carotid revascularizations.
CO
136 cases
Control group
1503 cases 𝑃
Neurological deaths 2 1.5% 6 0.4% 0.283
Major stroke 6 4.4% 18 1.2% 0.009
Minor stroke 1 0.7% 8 0.5% 0.765
Overall neurological morbidity∗ 7 5.1% 26 1.7% 0.016
Overall neurological complications-combined endpoint∘ 9 6.6% 32 2.1% 0.003
CO: contralateral carotid occlusion; ∗major + minor strokes; ∘neurological death + major strokes + minor strokes.
Table 3: Multivariate analysis of the role side of brain infarct related to the operated carotid artery on perioperative neurological outcome
(stroke and stroke-related mortality) in 1639 primary carotid revascularizations (overall population brain lesion analysis OR 0.86, 95% CI
0.42–1.77, 𝑃 = 0.69).
CO group Control group
OR 95% CI 𝑃 OR 95% CI 𝑃
Brain lesion overall 4.47 1.81–11.04 0.0003 0.56 0.23–1.34 0.19
Ipsilateral brain lesion 3.6 0.45–28.61 0.19 0.33 0.08–1.4 0.11
Contralateral brain lesion 3.24 0.95–10.96 0.04 0.6 0.08–4.5 0.62
Bilateral brain lesion 8.14 1.72–38.41 0.001 0.37 0.05–2.72 0.30
CO: contralateral carotid occlusion.
shunt group and 5 patients in the nonshunt group presented
overall perioperative neurological complications combined
endpoint). All other variables analysed did not show any
statistical difference between favourable and unfavourable
outcome.Those same factors were not significantly associated
with complications in the control group.
3.5. Between Group Analysis of Risk Factors for Postopera-
tive Neurological Complications. The abovementioned risk
factors (>74 years derived from the intragroup continuous
data analysis of age, and preoperative brain damage) were
subsequently analyzed for their role in the development
of postoperative neurological complications in the whole
sample. Odds ratio analysis disclosed that the association
of ipsilateral carotid stenosis and contralateral occlusion
with bilateral or contralateral preoperative brain ischemic
lesion exposed the CEA patient to a higher surgical risk of
postoperative neurological complications (OR 8.1, 95% CI
1.72–38.41, 𝑃 = 0.001; and OR 3.2, 95% CI 0.95–10.96, 𝑃 =
0.04, resp., Table 3). Similarly, in CEA patients the association
of ipsilateral stenosis and contralateral occlusion with age
>74 years increased significantly this risk (OR 11.5, 95% CI
4.08–32.62, 𝑃 < 0.0001). Further, in CO CEA patients the
association of age>74 years with ipsi/bilateral or contralateral
preoperative brain damage showed an augmented surgical
risk of brain lesions (OR 19.9; 95%CI 1.77–224.56,𝑃 = 0.0006;
OR 40.9, 95% CI 5.61–298.05, 𝑃 < 0.0001, resp., Table 4).
Among 11 CO patients presenting both age >74 years and
a preoperative brain infarct, 5 (45.5%) presented postoper-
ative neurological complications. Analysis of the causes of
postoperative neurological complications in those 5 patients
disclosed that one patient suffered from hemorrhagic trans-
formation of a preoperative brain infarct anddied; one patient
suffered from acute postoperative carotid thrombosis with
immediate neurological deterioration and slow recovery in
the following months after CEA; one patient with a very
small internal carotid artery (maximal external diameter
4mm) who did not tolerate carotid clamping, in which a 3 ×
4mmSundt shuntwas employed, presented an intraoperative
cerebral hypoperfusion with prompt recovery of the post-
operative neurological deficit; and two patients presented a
postoperative neurological deficit related to the contralateral
carotid occlusion (watershed infarct) with a residual small
deficit in the postoperative period.
4. Discussion
4.1. Our Experience. In the present series CEA patients
affected by carotid stenosis and contralateral occlusion pre-
sented significantly higher perioperative major stroke rate
(𝑃 = 0.009), overall neurological morbidity (𝑃 = 0.01),
and overall neurological complication rates (𝑃 = 0.003)
compared to control group of patients. From our experience
the CO sample, as a whole, represents a subset of patients at
higher surgical risk for CEA when compared to the general
patients affected by carotid stenosis requiring intervention,
in accordance with previous reports [1, 3, 8, 14–16]. Never-
theless, when dealing with CO patients, some peculiarities
must be taken into account and some ensuing considerations
could be made. First, in our series CO patients demographics
analysis showed a higher frequency of smoking history, other
vascular district involvements in the atherosclerotic process
(i.e., peripheral arterial disease), neurological symptoms
history, and, of course, presence of previous brain infarction
on neuroimaging.Those data are in accordance with previous
studies by Julia et al. [17] and Rockman [6]. Moreover,
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Table 4: Multivariate analysis of the role of age >74 years and brain lesion by side in 1639 primary carotid revascularizations.
OR 95% CI 𝑃
CO + >74 years 11.54 4.08–32.62 <0.0001
Control group + >74 years 0.57 0.25–1.29 0.17
CO + >74 years + contralateral brain lesion 40.92 5.61–298.05 <0.0001
CO + >74 years + ipsi- or bilateral brain lesion 19.95 1.77–224.56 0.0006
CO + >74 years + brain lesion overall 28.68 7.76–105.93 <0.0001
CO: contralateral carotid occlusion.
those patients are generally younger when necessitating a
carotid revascularization. This seems to define the picture of
a population at high risk for any surgical procedure, given the
extensive involvement of the blood vessels in the atheroscle-
rotic process [18–23]. This peculiarity is underlined by the
presence of a preoperative neurological symptomatology in
64% of patients in our series, since the population ana-
lyzed presented more frequently carotid-related symptoms
and more frequently a brain infraction on neuroimaging
contralateral to the side affected by the stenosis. So the brain
in those patients is somewhat more fragile and less prone
to tolerate carotid clamping during CEA or also eventual
small and clinically silent ischemic brain lesions (eventually
accompanied by perilesional oedema) caused by microem-
bolic plaque particles dislodged during CEA. Ultimately, it
could be speculated that the brain in CO patients could have
less cerebral functional reserve [16]. Sam et al. [24] have
recently reported a significant reduction in cerebrovascular
reactivity in anterior circulation of the brain hemisphere
ipsilateral to a carotid stenoocclusive disease, thus implying
that unilateral carotid stenosis affects the vascular reserve
of both sides of the brain, so not only the hemisphere
ipsilateral to an occlusion, but also the contralateral one. To
further support the theory of a hemodynamic impairment
in patients with stenosis and contralateral occlusion Oka
et al. [25] demonstrated increased cerebral blood flow and
cerebrovascular reactivity in both hemispheres 3–6 months
after carotid stenosis treatment. In our series in CO patients
immediate neurological complications were related to carotid
embolism in 5 cases (55%) and to hypo- or reperfusion
in 4 cases (45%), thus accounting for a frailer brain in
those patients. These data demonstrate relevant differences
concerning causes of complications in comparison with the
control sample where hypo- or reperfusion were respon-
sible for postoperative complications in 2/36 cases (5.5%),
strengthening the assumption that CO patients present with
an increased perfusion instability [16].
Such susceptibility of the brain with respect to any type
of ischemic insult in those patients is sustained also by the
increased need for shunt implantation during CEA in CO, in
accordance with previous reports [6, 9, 26]. Some conflicting
data are reported in the literature concerning the need
for shunt implantation in CO patients: while some authors
advocate shunt implantation in all patients with CO [27],
others recommend selective shunting [28] or no shunting at
all [29, 30]. To add to thematter, a recent study byGoodney et
al. [31] showed that shunt use for CO patients during CEA is
associated with fewer complications, but only if the surgeon
used a shunt as part of his or her routine practice in CEA.
A careful intragroup analysis of CO population has
highlighted that some additional preoperative risk factors
can enhance the neurological risk in CEA. In our experience
presence of brain infarct on preoperative neuroimaging in
CO patients decreases the capability of tolerating any kind of
ischemic insult, as demonstrated by a 4.4-fold neurological
risk increase in this subset of patients (Table 3). From our
analysis patients with bilateral or contralateral brain lesions
seem at higher risk for neurological complication follow-
ing carotid revascularization. Unfortunately, no information
was available in our database concerning the size of brain
ischemic lesions but we can speculate that contralateral dam-
age in our series, namely, ipsilateral to a carotid occlusion,
might be quite wide and so it can reinforce the persuasion
that those patients’ brains are less prone to tolerate any kind
of hemodynamic or embolic ischemic insult. On the other
hand, an incomplete Willis circle might justify the higher
incidence of old brain infarcts and liability to new ischemic
events. Moreover, advanced age, defined in our experience
by the presence of more than 74 years, further increases the
neurological risk by 11.5-fold (Table 4). The elderly seem at
higher risk of brain hemodynamic impairment during carotid
clamping per se [32]. When advanced age and preoperative
brain infarct are combined, the risk of postoperative neuro-
logical complications reached prohibitive values in our series
(OR 28.6 in CO population, Table 4). Analysis of specific
complications developed in 5 out of 11 CO patients presenting
both age >74 years and a preoperative brain infarct has
confirmed the higher fragility of the brain in those patients.
Except for one case of carotid thrombosis, probably related to
a technical defect in CEA, in two patients the postoperative
neurological deficit was related to a global brain hypoperfu-
sion not clinically evident during CEA and in another one to
a hypoperfusion due to a very small carotid artery in which a
small shunt had been implanted, thus causing a damage in the
hemisphere ipsilateral to the occluded carotid artery. In one
last case a preoperative brain lesion underwent a hemorrhagic
transformation thus underlining the weakness produced in
the blood-brain barrier by a previous damage.
Even if a higher neurological surgical risk in patients
affected by carotid stenosis and contralateral occlusion has
been reported in numerous series [8, 14, 15], some single-
center experiences have derived different conclusions [27,
33]. This is why nowadays no clear indications for carotid
treatment are recognized for this group of patients [34].
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4.2. Data from the Literature. Historical data onCEApatients
have shownCO to be a significant risk factor for perioperative
development of neurological complications [1–3, 15]. A post
hoc analysis of patients enrolled in NASCET [15] and in
the Ontario Carotid Endarterectomy Registry [3] reported a
significantly higher incidence of 30-day adverse neurological
events in patients with CO. More recently two meta-analyses
of patients undergoing revascularization when presenting a
contralateral carotid occlusionwere independently published
in 2013 [16, 35].
Antoniou et al. [16] performed a systematic review of
electronic information sources to identify studies comparing
perioperative and early outcomes of CEA in patients with
occluded and patent contralateral carotid arteries. Thirty
articles were included for meta-analysis, comprising 27265
patients having undergone 28846 CEAs between 1961 and
2009. Among them 3120 patients presented a carotid occlu-
sion contralateral to the operated side. The authors’ last
electronic search was run in August 2012 [16]. The incidence
of stroke was 3.3% in the occluded contralateral carotid group
and 1.9% in the patent contralateral carotid group (OR 1.65;
95% CI 1.30–2.09; 𝑃 < 0.001). No significant heterogeneity
among the studies was identified and no statistically signif-
icant association between the time of publication of studies
and the likelihood of developing perioperative neurological
complications was found. Analysis of complications related
to routine or selective shunting was not performed given the
lack of significant heterogeneity of outcome in the selected
studies. The authors concluded that “patients undergoing
CEA in the presence of an occluded contralateral carotid
artery had increased perioperative and early postoperative
risk,” but they also pointed out a wide variety among studies
of degree of stenosis, indication for treatment, exclusion
of recurrent stenosis, carotid disease diagnostic methods,
selection criteria for patients enrolment, examination of the
status of collateral vertebrobasilar circulation, combination of
results in symptomatic and asymptomatic patients, anesthetic
methods, surgical techniques, and shunt use [16].
Faggioli et al. [35] performed a systematic review of
papers published up to March 2012 reporting results on
patients with carotid stenosis and contralateral occlusion
submitted to either CEA or CAS. They included in the
analysis 27 papers on CEA and 6 on CAS. The authors
reported CO to be considered a significant risk factor for
stroke and death in CEA (OR 1.82; 95% CI 1.57–2.11; 𝑃 <
0.00001) but not in CAS (OR 1.22; 95% CI 0.60–2.49; 𝑃 <
0.58) [35]. In CEA studies the authors performed a subgroup
analysis reporting separate results for symptomatic patients
(OR 2.43; 95%CI 1.07–5.50;𝑃 = 0.03), asymptomatic patients
(OR 1.83; 95%CI 1.25–2.68;𝑃 = 0.002), and patients included
in studies with higher statistical power (OR 1.75; 95%CI 1.44–
2.12; 𝑃 < 0.00001), thus concluding that in all analysis CO
represents a significant risk factor for adverse neurological
events. Furthermore, the analysis performed with respect to
shunt use revealed that in studies reporting both selective and
routine shunting an increased risk of stroke and death can
be encountered in CO patients (resp., OR 1.83; 95% CI 1.34–
2.52; 𝑃 < 0.0002; OR 2.14; 95% CI 1.28–3.32; 𝑃 < 0.0007),
while in studies reporting no shunt use that riskwas increased
but not significantly (OR 2.61; 95% CI 0.91–7.46; 𝑃 < 0.07).
No CAS studies were deemed appropriate for the subgroup
meta-analysis [35]. Nevertheless, based on historical data
derived fromRCTs, showing an increased risk of neurological
complications in CO patients, a CAS treatment has been
proposed and performed in the majority of those patients
for many years. Keldahl et al. [36] retrospectively reviewed
417 CAS procedures performed between May 2001 and July
2010 and concluded that a preexisting CO does not seem to
adversely impact CAS outcomes. On the contrary, a report
by Brewster et al. [37] has pointed out that although CEA and
CAS can both be performed with satisfactory perioperative
results, the observed outcomes do not support the presence of
contralateral carotid occlusion as a selection criteria for CAS
over CEA in the absence of other indications. More recently,
more papers have fuelled the debate on CO patients [38–40].
Yang et al. [38] have found that CO has no adverse impact on
the development of postprocedural stroke after either CEA
or CAS, reporting a stroke rate of 2.3% in 698 CEA patients
routinely submitted to shunt implantation and 4% in 455
CAS patients. Ricotta et al. [39] have derived quite different
conclusions, showing that in CEA patients CO significantly
affects perioperative stroke rates (3.1% versus 1.1% in patients
without CO, 𝑃 < 0.0001), while in CAS patients CO does
not affect periprocedural stroke rates (2.1% versus 2.3% in
patients without CO, 𝑃 = 0.82). Kang et al. [40] reported
again CO to be among predictors of any stroke at 30 days
after CEA and also of long-term ipsilateral stroke (HR 2.06;
𝑃 = 0.025).
On the other hand, alternative strategies, such as medical
therapy alone, appeared to be of low efficacy in patients
affected by CO in historical studies [15, 41]. In those papers
reporting on patients suffering from internal carotid artery
stenosis and contralateral occlusion alarmingly high rates of
recurrent stroke, ranging from 20% within 3 years to 34%
within 51 months of follow-up in medically-treated patients,
are recorded [41]. Data from NASCET [15] reported a 14.3%
risk of stroke in CO patients submitted to CEA, but a 69.4%
2-year risk of stroke in those patients treated by medical
therapy alone, thus leaving very short room to the latter,
when considering the whole population of patients affected
by CO. It must be acknowledged that optimal medical
treatment has significantly improved since those cited studies
were conducted, making it possible that medical therapy
alone in asymptomatic patients with CO, as well as the so-
called “high-risk” categories, should be considered the best
treatment in the near future [42]. Hence, it is of outmost
importance to identify those CO patients with additional
risk factors for carotid surgery who can better be treated by
optimized medical therapy and strict surveillance in absence
of recent neurological symptoms.
5. Conclusions
In our experience CEA patients with CO present with
a heavier burden of diffuse atherosclerotic disease when
compared to control sample of CEA patients.
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Moreover, they are at higher risk for postoperative neuro-
logical complications because of a higher brain susceptibility
mainly encountered in a small subset of patients presenting
association of twomost significant risk factors for developing
complications (advanced age, i.e.,>74 years, and preoperative
brain infarction on preoperative CT scans). In those cases
the risk of surgery seems to be excessive, and exclusion from
surgery with an alternative interventional or conservative
approach could be worthwhile. Future studies evaluating the
role of medical therapy over carotid intervention in this
subgroup of patients are mandatory.
Conflict of Interests
The authors declare that there is no conflict of interests
regarding the publication of this paper.
References
[1] North American Symptomatic Carotid Endarterectomy Trial
Collaborators, “Beneficial effect of carotid endarterectomy in
symptomatic patients with high-grade carotid stenosis,” The
New England Journal of Medicine, vol. 325, pp. 445–453, 1991.
[2] C. Warlow, “MRC European Carotid Surgery Trial: interim
results for symptomatic patients with severe (70–99%) or with
mild (0–29%) carotid stenosis,” The Lancet, vol. 337, no. 8752,
pp. 1235–1243, 1991.
[3] J. V. Tu, H. Wang, B. Bowyer, L. Green, J. Fang, and D. Kucey,
“Risk factors for death or stroke after carotid endarterectomy:
observations from the Ontario Carotid Endarterectomy Reg-
istry,” Stroke, vol. 34, no. 11, pp. 2568–2573, 2003.
[4] J. F. Toole, “Endarterectomy for asymptomatic carotid artery
stenosis,” Journal of the American Medical Association, vol. 273,
no. 18, pp. 1421–1428, 1995.
[5] L. L. Nguyen, M. S. Conte, A. B. Reed, and M. Belkin, “Carotid
endarterectomy: who is the high-risk patient?” Seminars in
Vascular Surgery, vol. 17, no. 3, pp. 219–223, 2004.
[6] C. Rockman, “Carotid endarterectomy in patients with con-
tralateral carotid occlusion,” Seminars in Vascular Surgery, vol.
17, no. 3, pp. 224–229, 2004.
[7] C. Domenig, A. D. Hamdan, A. K. Belfield et al., “Recurrent
stenosis and contralateral occlusion: high-risk situations in
carotid endarterectomy?”Annals of Vascular Surgery, vol. 17, no.
6, pp. 622–628, 2003.
[8] A. B. Reed, P. Gaccione, M. Belkin et al., “Preoperative risk
factors for carotid endarterectomy: defining the patient at high
risk,” Journal of Vascular Surgery, vol. 37, no. 6, pp. 1191–1199,
2003.
[9] P. Locati, A. M. Socrate, G. Lanza, A. Tori, and S. Costantini,
“Carotid endarterectomy in an awake patient with contralateral
carotid occlusion: influence of selective shunting,” Annals of
Vascular Surgery, vol. 14, no. 5, pp. 457–462, 2000.
[10] E. Ballotta, L. Renon, G. Da Giau, B. Barbon, O. Terranova, and
C. Baracchini, “Octogenarians with contralateral carotid artery
occlusion: a cohort at higher risk for carotid endarterectomy?”
Journal of Vascular Surgery, vol. 39, no. 5, pp. 1003–1008, 2004.
[11] T. G. Brott, J. L. Halperin, S. Abbara et al., “2011 ASA/ACCF/
AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/
SVM/SVS guideline on the management of patients with
extracranial carotid and vertebral artery disease : executive
summary,” Catheterization and Cardiovascular Interventions,
vol. 81, no. 1, pp. E76–E123, 2013.
[12] C. D. Liapis, P. R. Bell, D. Mikhailidis et al., “ESVS guidelines.
Invasive treatment for carotid stenosis: indications, techniques,”
European Journal of Vascular and Endovascular Surgery, vol. 37,
supplement 4, pp. 1–19, 2009.
[13] U. Fischer, A. Baumgartner, M. Arnold et al., “What is a minor
stroke?” Stroke, vol. 41, no. 4, pp. 661–666, 2010.
[14] P. P. Goodney, D. S. Likosky, and J. L. Cronenwett, “Factors
associated with stroke or death after carotid endarterectomy in
Northern New England,” Journal of Vascular Surgery, vol. 48,
no. 5, pp. 1139–1145, 2008.
[15] A. P. Gasecki, M. Eliasziw, G. G. Ferguson, V. Hachinski, and
H. J.M. Barnett, “Long-termprognosis and effect of endarterec-
tomy in patients with symptomatic severe carotid stenosis
and contralateral carotid stenosis or occlusion: results from
NASCET,” Journal of Neurosurgery, vol. 83, no. 5, pp. 778–782,
1995.
[16] G. A. Antoniou, G. Kuhan, G. S. Sfyroeras et al., “Contralateral
occlusion of the internal carotid artery increases the risk of
patients undergoing carotid endarterectomy,” Journal of Vascu-
lar Surgery, vol. 57, no. 4, pp. 1134–1145, 2013.
[17] P. Julia, E. Chemla, F.Mercier, J.-M. Renaudin, and J.-N. Fabiani,
“Influence of the status of the contralateral carotid artery on the
outcome of carotid surgery,” Annals of Vascular Surgery, vol. 12,
no. 6, pp. 566–571, 1998.
[18] L. Cheng, Z. Wu, Y. Fu, F. Miao, J. Sun, and S. Tong, “Reorga-
nization of functional brain networks during the recovery of
stroke: a functional MRI study,” in Proceedings of the 34th
Annual International Conference of the IEEE Engineering in
Medicine and Biology Society (EMBS ’12), pp. 4132–4135, San
Diego, Calif, USA, September 2012.
[19] N. S. Ward, “Functional reorganization of the cerebral motor
system after stroke,”Current Opinion in Neurology, vol. 17, no. 6,
pp. 725–730, 2004.
[20] P.M. Rossini andG. Dal Forno, “Integrated technology for eval-
uation of brain function andneural plasticity,”PhysicalMedicine
and Rehabilitation Clinics of North America, vol. 15, no. 1,
pp. 263–306, 2004.
[21] S. Midwall, R. V. Swaminathan, K. Charitakis et al., “Impact of
peripheral vascular disease on short- and long-term outcomes
in patients undergoing non-emergent percutaneous coronary
intervention in the drug-eluting stent era,” Journal of Invasive
Cardiology, vol. 25, no. 3, pp. 132–136, 2013.
[22] D. J. O’Rourke, H. B. Quinton, W. Piper et al., “Survival in
patients with peripheral vascular disease after percutaneous
coronary intervention and coronary artery bypass graft
surgery,” The Annals of Thoracic Surgery, vol. 78, no. 2, pp.
466–470, 2004.
[23] M. Singh, R. J. Lennon, D. Darbar, B. J. Gersh, D. R. Holmes
Jr., and C. S. Rihal, “Effect of peripheral arterial disease in
patients undergoing percutaneous coronary intervention with
intracoronary stents,”Mayo Clinic Proceedings, vol. 79, no. 9, pp.
1113–1118, 2004.
[24] K. Sam, E. Small, J. Poublanc et al., “Reduced contralateral cere-
brovascular reserve in patients with unilateral steno-occlusive
disease,” Cerebrovascular Diseases, vol. 38, no. 2, pp. 94–100,
2014.
[25] F. Oka, H. Ishihara, S. Kato, M. Higashi, and M. Suzuki, “Cere-
bral hemodynamic benefits after contralateral carotid artery
stenting in patients with internal carotid artery occlusion,”The
8 International Journal of Vascular Medicine
American Journal of Neuroradiology, vol. 34, no. 3, pp. 616–621,
2013.
[26] M. J. Estruch-Pe´rez, A. Plaza-Mart´ınez,M. J. Herna´ndez-Ca´diz,
J. Soliveres-Ripoll, C. Solaz-Rolda´n, andM.M.Morales-Suarez-
Varela, “Interaction of cerebrovascular disease and contralateral
carotid occlusion in prediction of shunt insertion during carotid
endarterectomy,” Archives of Medical Science, vol. 8, no. 2, pp.
236–243, 2012.
[27] K. A. Coyle, R. B. Smith III, A. A. Salam, T. F. Dodson, E.
L. Chaikof, and A. B. Lumsden, “Carotid endarterectomy in
patients with contralateral carotid occlusion: review of a 10-year
experience,”Cardiovascular Surgery, vol. 4, no. 1, pp. 71–75, 1996.
[28] B. Cinar, O. S. Goksel, C. Karatepe et al., “Is routine intravascu-
lar shunting necessary for carotid endarterectomy in patients
with contralateral occlusion? A review of 5-year experience
of carotid endarterectomy with local anaesthesia,” European
Journal of Vascular and Endovascular Surgery, vol. 28, no. 5, pp.
494–499, 2004.
[29] J. E. Frawley, R. G. Hicks, L. J. Gray, and J. W. Niesche, “Carotid
endarterectomy without a shunt for symptomatic lesions asso-
ciated with contralateral severe stenosis or occlusion,” Journal of
Vascular Surgery, vol. 23, no. 3, pp. 421–427, 1996.
[30] A. H. Boontje, “Carotid endarterectomy without a temporary
indwelling shunt: results and analysis of back pressuremeasure-
ments,” Cardiovascular Surgery, vol. 2, no. 5, pp. 549–554, 1994.
[31] P. P. Goodney, J. B.Wallaert, S. T. Scali et al., “Impact of practice
patterns in shunt use during carotid endarterectomy with con-
tralateral carotid occlusion,” Journal of Vascular Surgery, vol. 55,
no. 1, pp. 61–71, 2012.
[32] D. Rosenthal, R. H. Rudderman, D. H. Jones et al., “Carotid
endarterectomy in the octogenarian: is it appropriate?” Journal
of Vascular Surgery, vol. 3, no. 5, pp. 782–787, 1986.
[33] A. F. AbuRahma, P. A. Stone, S. Abu-Halimah, and C. A.Welch,
“Natural history of carotid artery occlusion contralateral to
carotid endarterectomy,” Journal of Vascular Surgery, vol. 44, no.
1, pp. 62–66, 2006.
[34] K. I. Paraskevas and F. J. Veith, “The indications of carotid artery
stenting in symptomatic patients may need to be reconsidered,”
Annals of Vascular Surgery, vol. 29, no. 1, pp. 154–159, 2015.
[35] G. Faggioli, R. Pini, R. Mauro, A. Freyrie, M. Gargiulo, and A.
Stella, “Contralateral carotid occlusion in endovascular and sur-
gical carotid revascularization: a single centre experience with
literature review and meta-analysis,” European Journal of Vas-
cular and Endovascular Surgery, vol. 46, no. 1, pp. 10–20, 2013.
[36] M. L. Keldahl, M. S. Park, M. Garcia-Toca et al., “Does a
contralateral carotid occlusion adversely impact carotid artery
stenting outcomes?” Annals of Vascular Surgery, vol. 26, no. 1,
pp. 40–45, 2012.
[37] L. P. Brewster, R. Beaulieu, K. Kasirajan et al., “Contralateral
occlusion is not a clinically important reason for choosing
carotid artery stenting for patients with significant carotid
artery stenosis,” Journal of Vascular Surgery, vol. 56, no. 5, pp.
1291–1295, 2012.
[38] S. S. Yang, Y. W. Kim, D. I. Kim et al., “Impact of contralateral
carotid or vertebral artery occlusion in patients undergoing
carotid endarterectomy or carotid artery stenting,” Journal of
Vascular Surgery, vol. 59, no. 3, pp. 749–755, 2014.
[39] J. J. Ricotta II, G. R. Upchurch Jr., G. S. Landis et al., “The
influence of contralateral occlusion on results of carotid inter-
ventions from the society for vascular surgery vascular registry,”
Journal of Vascular Surgery, vol. 60, no. 4, pp. 958–964, 2014.
[40] J. Kang, M. F. Conrad, V. I. Patel et al., “Clinical and anatomic
outcomes after carotid endarterectomy,” Journal of Vascular
Surgery, vol. 59, no. 4, pp. 944–949, 2014.
[41] E. R. Hammacher, B. C. Eikelboom, T. J. Bast, R. De Geest, and
F. E. Vermeulen, “Surgical treatment of patients with a carotid
artery occlusion and a contralateral stenosis,” Journal of Cardio-
vascular Surgery, vol. 25, no. 6, pp. 513–517, 1984.
[42] A. L. Abbott,M. A. Adelman, A. V. Alexandrov et al., “Why calls
formore routine carotid stenting are currently inappropriate: an
international, multispecialty, expert review and position state-
ment,” Stroke, vol. 44, no. 4, pp. 1186–1190, 2013.
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
